Skip to contentDP VII ASSOCIATES LP — Orexigen Therapeutics, Inc. insider: 74 transactions · InsiderLensDP VII ASSOCIATES LP
- 10% owner at Orexigen Therapeutics, Inc. · on record since Dec 11, 2008
- 10% owner at CADENCE PHARMACEUTICALS INC · on record since Feb 20, 2009
- 10% owner at Clovis Oncology, Inc. · on record since Nov 21, 2011
- 10% owner at ZOGENIX, INC. · on record since Nov 22, 2010
- 10% owner at Neutral Tandem Inc · on record since Nov 19, 2013
- 10% owner at Esperion Therapeutics, Inc. · on record since Jun 25, 2013
- 10% owner at Evoke Pharma Inc · on record since Sep 30, 2013
- 10% owner at Achaogen Inc · on record since Mar 17, 2014
- 10% owner at OBALON THERAPEUTICS INC · on record since Oct 14, 2016
- 10% owner at Neothetics, Inc. · on record since Nov 26, 2014
- 10% owner at Regado Biosciences Inc · on record since May 6, 2015
Insider trading activity of DP VII ASSOCIATES LP
- Transactions on record
- 74
- since Dec 11, 2008
- Open-market buys
- 21
- $833.3K
- Open-market sells
- 5
- $32.9K
- Companies traded
- 11
- last filing Nov 3, 2016
Figures computed from official regulatory filings — methodology.
Companies where DP VII ASSOCIATES LP has traded
- Regado Biosciences Inc1 tx · $1.3M · Nov 3, 2016
- OBALON THERAPEUTICS INC4 tx · Oct 14, 2016
- Evoke Pharma Inc3 tx · $27.6K · May 27, 2016
- Neothetics, Inc.11 tx · $75.1K · Dec 10, 2014
- CADENCE PHARMACEUTICALS INC5 tx · $715.7K · Mar 21, 2014
- Achaogen Inc4 tx · Mar 17, 2014
- Neutral Tandem Inc6 tx · Nov 19, 2013
- Esperion Therapeutics, Inc.5 tx · $67.1K · Jul 2, 2013
- Orexigen Therapeutics, Inc.18 tx · $402.3K · Dec 22, 2011
Track record of DP VII ASSOCIATES LP
Statistical track record
Free- Open-market buys
- 22
- Last buy
- Jul 1, 2013
Win rates and median returns are available with a free account (5 insiders/month).
Create a free account→Transaction history of DP VII ASSOCIATES LP
Co-insiders of DP VII ASSOCIATES LP
This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →
9 tx · $203.1K · Nov 21, 2011
Kamdar Kim P.CADENCE PHARMACEUTICALS INC +8
| Company | Filed | Type | Qty | Price | Value · USD | Src |
|---|
| Nov 3, 2016 | Other | -47,613 | 28.35 USD | $1.3M | SEC |
| Oct 14, 2016 | OtherD | -20,583 | 0.00 USD | $0 | SEC |
| Oct 14, 2016 | Other | 49,570 | — | — | SEC |
| Oct 14, 2016 | OtherD | -14,271 | 0.00 USD | $0 | SEC |
| Oct 14, 2016 | OtherD | -11,083 | 0.00 USD | $0 | SEC |
| May 27, 2016 | Sell | -5,880 | 4.70 USD | $27.6K | SEC |
| Dec 10, 2014 | ExerciseD | -1,570 | 0.00 USD | $0 | SEC |
| Dec 10, 2014 | OtherD | -104,247 | 0.00 USD | $0 | SEC |
| Dec 10, 2014 | ExerciseD | -2,827 | 0.00 USD | $0 | SEC |
| Dec 10, 2014 | OtherD | -12,578 | 0.00 USD | $0 | SEC |
| Dec 10, 2014 | Other | -1,725 | 14.00 USD | $24.2K | SEC |
| Dec 10, 2014 | Exercise | 2,827 | 8.54 USD | $24.1K | SEC |
| Dec 10, 2014 | OtherD | -102,282 | 0.00 USD | $0 | SEC |
| Dec 10, 2014 | Other | 46,311 | — | — | SEC |
| Dec 10, 2014 | Exercise | 1,570 | 8.54 USD | $13.4K | SEC |
| Dec 10, 2014 | OtherD | -36,913 | 0.00 USD | $0 | SEC |
| Dec 10, 2014 | Other | -958 | 14.00 USD | $13.4K | SEC |
| Mar 21, 2014 | Other | -50,743 | 14.00 USD | $710.4K | SEC |
| Mar 17, 2014 | Other | 33,890 | — | — | SEC |
| Mar 17, 2014 | OtherD | -15,799 | 0.00 USD | $0 | SEC |
| Mar 17, 2014 | OtherD | -10,661 | 0.00 USD | $0 | SEC |
| Mar 17, 2014 | OtherD | -7,430 | 0.00 USD | $0 | SEC |
| Nov 19, 2013 | OtherD | 6,008 | 0.00 USD | $0 | SEC |
| Nov 19, 2013 | Other | 54,390 | — | — | SEC |
| Nov 19, 2013 | OtherD | -6,071 | 0.00 USD | $0 | SEC |